Modcid LS 75mg/20mg Capsule SR is a modified-release formulation containing levosulpiride (75mg) and rabeprazole (20mg) in a single capsule. This product is indicated for the treatment of gastroesophageal reflux disease (GERD) and erosive esophagitis in adult patients. The combination of levosulpiride and rabeprazole provides effective acid suppression and relief from symptoms such as heartburn and regurgitation. Levosulpiride, a substituted benzamide, has potent antiemetic and antisecretory properties, while rabeprazole, a proton pump inhibitor, selectively and irreversibly inhibits gastric acid production. The modified-release formulation allows for controlled release of the active ingredients over an extended period, providing 24-hour acid suppression and sustained relief from symptoms. Modcid LS 75mg/20mg Capsule SR is contraindicated in patients with known hypersensitivity to any component of the formulation, and its use is generally recommended in patients with a history of gastrointestinal disease or who are taking medications that may interact with the product.